{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }} (ARIDS)

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Survey Questionnaire

(Kindly fill in the relevant information or tick, as appropriate.)


A multi-centric, cross-sectional, observational survey study to understand the role of combination of lutein, zeaxanthin, vitamins and minerals (I-Site AF capsule) in age-related macular degeneration (AMD)
  1. How many years have you been practicing ophthalmology? *

  2. As per your clinical practice, what is the approximate number of patients with age-related macular degeneration (AMD) present to you in your practice every month? *

  3. As per your clinical practice, which is the most common age group in patients diagnosed with AMD? *

  4. What is the approximate percentage of AMD patients with co-morbidities, as per observations in your practice? (Please tick the applicable option) *

  5. Kindly rank the most common co-morbidities observed in AMD patients as per your practice? (Please rank from rank 1 to rank 5 as from most common to least common comorbidity) *
    6. Name Rank
    1 2 3 4 5
    Glaucoma
    Dry eye disease
    Cataract
    Diabetes

  6. Do you routinely recommend antioxidant and micronutrient supplementation for patients with AMD? *

  7. How frequently do you recommend antioxidant and micronutrient supplementation for patients with early-stage AMD? *

  8. Which specific antioxidants and micronutrients do you commonly recommend for AMD management? (Select all that apply) *
  9. How do you assess the effectiveness of antioxidant and micronutrient supplementation in AMD management? *

  10. How frequently do you recommend follow-up visits for patients using antioxidant and micronutrient supplementation for AMD management? *

  11. How do you determine the appropriate dosage and duration of antioxidant and micronutrient supplementation for individual patients? *

  12. What are the key benefits or expected outcomes of antioxidant and micronutrient supplementation in AMD management, based on your experience? (Select all that apply) *
  13. Do you collaborate with other healthcare professionals, such as nutritionists or dietitians, to optimize antioxidant and micronutrient supplementation for AMD management? *

  14. Please rate your level of agreement with the statement: "Antioxidant and micronutrient supplementation plays a significant role in the management of AMD." *

  15. Please rate your level of confidence in the efficacy of antioxidant and micronutrient supplementation for slowing the progression of AMD. *

  16. Please rate your level of agreement with the statement: "Combination supplements containing multiple antioxidants and micronutrients are more effective in AMD management than individual supplements." *

  17. Please rate your level of agreement with the statement: "Antioxidant and micronutrient supplementation should be recommended as a preventive measure for patients at high risk of developing AMD." *

  18. Are there any specific patient factors or conditions that require special considerations in recommending antioxidant and micronutrient supplementation for AMD management? (Select all that apply) *
  19. How do you educate your patients about the importance of antioxidant and micronutrient supplementation for AMD management? *

  20. Do you encounter challenges in patient adherence to antioxidant and micronutrient supplementation for AMD management? *

  21. If yes, what strategies do you employ to address these challenges and improve patient adherence?

  22. What factors influence your decision to continue antioxidant and micronutrient supplementation for AMD management in a patient? *

  23. What factors influence your decision to discontinue antioxidant and micronutrient supplementation for AMD management in a patient? *

  24. Are you familiar with the I Site AF capsules - a combination of lutein, zeaxanthin, vitamins, and minerals? *

  25. How do you recommend I Site AF capsules - a combination of lutein, zeaxanthin, vitamins, and minerals to your patients with AMD? *

  26. What are the primary reasons for prescribing a combination of lutein, zeaxanthin, vitamins, and minerals to your patients with AMD? (Select all that apply) *
  27. How would you rate the efficacy of I Site AF capsules - a combination of lutein, zeaxanthin, vitamins, and minerals in your patients with AMD in terms of slowing the progression of AMD? (Please tick the applicable option) *

  28. How would you rate the efficacy of I Site AF capsules - a combination of lutein, zeaxanthin, vitamins, and minerals in your patients with AMD in terms of maintaining visual acuity and enhancing visual function? (Please tick the applicable option) *

  29. How would you rate I Site AF capsules - a combination of lutein, zeaxanthin, vitamins, and minerals in your patients with AMD in terms of compliance in patients? (Please tick the applicable option) *

  30. How do you determine the appropriate dosage and duration of I Site AF capsules - a combination of lutein, zeaxanthin, vitamins, and minerals in your patients with AMD medication for individual patients? (Select all that apply) *
  31. For what duration do you usually prescribe I Site AF capsules - a combination of lutein, zeaxanthin, vitamins, and minerals in your patients with AMD? (Select all that apply) *
  32. How do you educate your patients about the importance of adherence to medication and treatment plans for AMD? *

  33. In your opinion, are there any areas for improvement in the management of AMD? *

  34. If yes, what changes or improvements would you suggest?

  35. Is there anything you would like to share about your experience with I Site AF capsules - a combination of lutein, zeaxanthin, vitamins, and minerals in your patients with AMD or any suggestions for their optimal use? *